Inhaled corticosteroids (ICS) and bone mineral density (BMD) - a follow-up study. The bronchial obstruction in Nord-Trøndelag study (BONT) Source: Eur Respir J 2004; 24: Suppl. 48, 601s Year: 2004
A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015
Indacaterol/glycopyrronium (IND/GLY) reduces exacerbation and improves lung function versus salmeterol/fluticasone (SFC) in patients with and without prior ICS use: The FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021
Absence of nonspecific bronchial responsiveness (NSBR) in occupational asthma (OA): A case-series study Source: Annual Congress 2012 - Occupational asthma Year: 2012
Use of inhaled corticosteroids and the risk of osteoporosis: an international cohort study Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function Year: 2018
A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
The prevalence of bronchial asthma symptoms among adult population of Moscow (a population-based study). Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018
Lung function, bronchial hyperresponsiveness (BHR) and metabolic risk factors in adults: Preliminary results from the gene environment interaction in respiratory disease (GEIRD) survey Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
Effect of inhaled steroids on lung function in young children: a cohort study Source: Eur Respir J 2004; 23: 869-875 Year: 2004
Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
Inhaled antibiotic treatment reduces the frequency of infective exacerbations in bronchiectasis: a single center, real life study Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with medium-dose ICS/LABA therapy (on GINA step 4) prior to study entry: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021
Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis) Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018
Budesonid/formoterol easyhaler: clinical efficiency and adherence to treatment in patients with partly controlled bronchial asthma (BA). Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Safety of bronchial thermoplasty (bt), a novel procedure for severe asthma; positive safety profile in the air2 trial Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009
The concept study: comparative influence of two treatment strategies on airway response to AMP Source: Annual Congress 2005 - Combination therapy for asthma. Which, why and how? Year: 2005
Inhaled formulation of angiotensin-(1-7) produces lung protective effects in a model of chronic asthma. Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018